Benzinga
Benzinga
Benzinga
mardi, septembre 29

Nautilus Biotechnology Inc

NAUTNASDAQ
Trade with Public
Trade with Public
$1.36
0.2522.97%
À la clôture: Sep 29, 5:00 PM EST
$1.46
0.0956.96%
Après les heures: 6:03 PM EST
PRO
Pourquoi cela bouge-t-il ?:Nautilus Biotechnology shares are trading higher after Roth Capital initiat...
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatComparerOptionsRapport sur les stocks

Nautilus Biotechnology Financials

Nautilus Biotechnology (NAUT) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Nautilus Biotechnology Q2 EPS $(0.11) Beats $(0.14) Estimate, Sales $190.000K

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 8.33 percent increase over losses of $(0.12) per share
Benzinga Newsdesk

Earnings Scheduled For April 28, 2026

Benzinga Insights

PRO
Nautilus Biotechnology Q1 EPS $(0.12) Beats $(0.17) Estimate

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.17) by 25 percent. This is a 7.69 percent increase over losses of $(0.13) per share
Benzinga Newsdesk

PRO
Nautilus Does Not Anticipate Material Revenue In 2026 From Early Access Program Engagement

Benzinga Newsdesk

PRO
Nautilus Biotechnology Q4 EPS $(0.11) Beats $(0.14) Estimate

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 21.43 percent increase over losses of $(0.14) per share
Benzinga Newsdesk

Earnings Scheduled For October 28, 2025

Benzinga Insights

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved